Originally posted by KerryOdair
View Post
One measure you should apply when you get the data is the distribution of coverage across the Y. Getting uniform capture is not easy, especially with lots of repeats.
On the business side, I'm glad someone is making a go at it & would be happy to see a market. Perhaps they have a very low cost business model, serving primarily as a pass-through to a large sequencing provider. Just that realistically the number of men willing to pay $1.3K for this information is not 0 (clearly!) but unlikely to support a big business. Perhaps they will be acquired by 23andme; otherwise they may not be around very long.
Comment